Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).
Gaddie IB, Donnenfeld ED, Karpecki P, Vollmer P, Berdy GJ, Peterson JD, Simmons B, Edell ARP, Whitson WE, Ciolino JB, Baba SN, Holdbrook M, Trevejo J, Meyer J, Yeu E; Saturn-2 Study Group. Gaddie IB, et al. Among authors: berdy gj. Ophthalmology. 2023 Oct;130(10):1015-1023. doi: 10.1016/j.ophtha.2023.05.030. Epub 2023 Jun 5. Ophthalmology. 2023. PMID: 37285925 Free article. Clinical Trial.
The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye.
Hovanesian JA, Keyser A, Berdy G, Sorensen R. Hovanesian JA, et al. Clin Ophthalmol. 2022 Nov 21;16:3841-3849. doi: 10.2147/OPTH.S387111. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36438591 Free PMC article.
Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.
Abelson MB, Berdy GJ, Mundorf T, Amdahl LD, Graves AL; Pemirolast study group. Abelson MB, et al. Among authors: berdy gj. J Ocul Pharmacol Ther. 2002 Oct;18(5):475-88. doi: 10.1089/10807680260362759. J Ocul Pharmacol Ther. 2002. PMID: 12419098 Clinical Trial.
Gastroesophageal reflux disease presenting as xerophthalmia.
Davitt BV, Berdy G, Kane RE. Davitt BV, et al. J Pediatr Ophthalmol Strabismus. 2001 Sep-Oct;38(5):315-7. doi: 10.3928/0191-3913-20010901-15. J Pediatr Ophthalmol Strabismus. 2001. PMID: 11587183 No abstract available.
31 results